Filtered By:
Source: Neurology
Condition: Encephalitis
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 24 results found since Jan 2013.
HSV-2 Encephalitis Presenting as Multifocal Ischemic Stroke (P4.375)
CONCLUSION A high index of suspicion needs to be maintained to diagnose infectious vasculitis. A history of immunosuppression and headache preceding cerebral infarction were important factors that ultimately led to the appropriate work up and diagnosis in this case. Lumbar puncture and prompt initiation of antiviral treatment is essential in stroke case of suspected CNS infection with HSV-2.Disclosure: Dr. Zhang has nothing to disclose. Dr. Sumida has nothing to disclose. Dr. Margolesky has nothing to disclose. Dr. Tornes has nothing to disclose. Dr. Ramos has nothing to disclose. Dr. Koch has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Zhang, F., Sumida, A., Margolesky, J., Tornes, L., Ramos, A., Koch, S. Tags: Cerebrovascular Case Reports Source Type: research
Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) with stroke like symptoms. A case report. (P5.104)
Conclusion: Clinicians should consider SREAT in the differential diagnosis of patients presenting with stroke like symptoms/vasculitis especially if investigations fail to establish a diagnosis.Disclosure: Dr. Javalkar has nothing to disclose. Dr. Abbas has nothing to disclose. Dr. Harris has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Javalkar, V., Abbas, S., Harris, M. Tags: Edema, Encephalopathy, and Encephalitis Source Type: research
Mitochondrial Encephalopathy with Lactic Acidosis and Stroke (MELAS) presenting as an apparent neoplastic process (P5.015)
CONCLUSION: MELAS can mimic more common disorders. The slow onset of her symptoms and the MRI's appearance led to suspicion for neoplasm. This is the first report to our knowledge where MELAS has presented as such. Documentation of this and other unusual presentations of mitochondrial disease is crucial to appropriate diagnosis of the condition.Disclosure: Dr. Rothstein has nothing to disclose. Dr. Haq has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Rothstein, A., Haq, I. Tags: Aging, Dementia, Cognitive, and Behavioral Neurology ePosters Source Type: research
Neurotoxocariasis, a treatable infectious etiology of Stroke (P3.318)
Conclusions:Toxocara infection is an uncommon but treatable etiology of stroke, and should be particularly considered in patients with eosinophilia, positive serology, myocarditis and embolic strokes.Disclosure: Dr. Garcia Monco has nothing to disclose. Dr. Azkune Calle has nothing to disclose. Dr. Ruisanchez nieva has nothing to disclose. Dr. Anguizola Tamayo has nothing to disclose. Dr. Pardina Vilella has nothing to disclose. Dr. Bocos Portillo has nothing to disclose. Dr. Gomez-Beldarrain has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Monco, J. G., Calle, I. A., nieva, A. R., Tamayo, D. A., Vilella, L. P., Portillo, J. B., Gomez-Beldarrain, M. Tags: Fungal and Parasitic Disease of the Nervous System Source Type: research
Misdiagnosis of CADASIL: A single Medical Center experience (P1.251)
Conclusions:CADASIL is the most prevalent monogenic cerebral small-vessel arteriopathy. Despite wide availability of genetic testing, misdiagnosis and delay diagnosis are common. We encourage for enhanced awareness of CADASIL among patients with migraines with aura, recurrent TIAs or subcortical ischemic strokes, and mood disorder, in order to provide appropriate multidisciplinary treatment, psychological support and genetic counselingStudy Supported by: n/aDisclosure: Dr. Ortiz-Garcia has nothing to disclose. Dr. Orjuela has nothing to disclose. Dr. Sweis has nothing to disclose. Dr. Biller has received personal compensat...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Ortiz-Garcia, J., Orjuela, K., Sweis, R., Biller, J. Tags: Genetic Stroke Syndromes, Biomarkers, and Translational/Basic Research Source Type: research
Primary Central Nervous System Vasculitis Triggered by Cytomegalovirus Encephalitis (P01.231)
CONCLUSIONS: Our case is the first reported case in the literature of proven CMV encephalitis triggering a subsequent non-infectious CNS vasculitis probably secondary to an autoimmune response. The absence of findings in the initial MRIs of the brain in spite of an intermittently symptomatic patient and the subsequent development of ischemic infarcts supports the theory of intermittent focal hypoperfusion, finally leading to infarction. The high clinical suspicion even with lack of clear evidence of the disease process and empirical treatment led to a successful clinical recovery.Disclosure: Dr. Rosales has nothing to disc...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Rosales, D., Garcia-Gracia, C., Salgado, E., Salanga, V. Tags: P01 Cerebrovascular Disease I Source Type: research
Pseudo-Hyperdense Middle Cerebral Artery in HSV Encephalitis (P02.025)
CONCLUSIONS: A hyperdense middle cerebral artery 'sign' can be associated with acute thrombus1, but several conditions (including encephalitis related cerebral edema) can give the appearance of a 'pseudo'-hyperdense MCA 'sign'.2 REFERENCES 1. Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia. Stroke. 2001 Jan;32(1):84-8. 2. Jha B, Kothari M. Pearls & oy-sters: hyperdense or pseudohyperdense MCA sign: a Damocles sword? Neurology. 2009 Jun 9;72(23):e116-7.Disclosure: Dr. Kenmuir has nothing to disclose. Dr. Totoraitis has nothing to di...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Kenmuir, C., Totoraitis, R., Jovin, T., Jadhav, A. Tags: P02 Cerebrovascular Disease II Source Type: research
Common etiologies of acute symptomatic seizures evolving from lateralized periodic discharges in patients monitored with continuous EEG (P2.233)
Conclusions:The most common high risk etiologies of acute symptomatic seizures evolving from lateralized periodic discharges in our cohort of patients were ischemic stroke, tumor, encephalitis, and subdural hematoma. Recognition of these etiologic factors may influence the duration of continuous EEG monitoring employed or the decision to institute seizure prophylaxis. A larger cohort of patients should be reviewed in a future study to confirm these findings.Disclosure: Dr. Mathew has nothing to disclose. Dr. Piran has nothing to disclose. Dr. Hantus has received personal compensation for activities with UCB Pharma as a con...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Mathew, S., Piran, P., Hantus, S., Malpe, C. Tags: Epilepsy and Clinical Neurophysiology: EEG and Imaging Source Type: research
Herpes-Simplex Virus 2: A New Player in Cerebral Vasculitis (P03.259)
CONCLUSIONS: The spectrum of atypical CNS manifestations related to HSV is emerging. We report a case of cerebral vasculitis, which was masked by the initial presentation as thalamic hemorrhage and followed by an encephalitic syndrome and multifocal ischemic stroke. The work-up revealed HSV-2 as a new and treatable cause of infectious vasculitis.Supported by: JS is supported by a scientific fellowship from the European Federation of Neurological Societies.Disclosure: Dr. Sellner has nothing to disclose. Dr. Wunderlich has nothing to disclose. Dr. Förschler has nothing to disclose. Dr. Nadas has nothing to disclose. Dr...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Sellner, J., Wunderlich, S., Forschler, A., Nadas, K., Hemmer, B., Zepper, P. Tags: P03 Infections I Source Type: research
Sinus Bradycardia Localizes Where? (P1.129)
Discussion: Different possible mechanisms of autonomic dysfunction are discussed based on the anatomy of the lesions. Such mechanisms include sympathetic withdrawal due to a lesion of the descending sympathetic tract causing parasympathetic disinhibition, imbalance within the parasympathetic system itself, or disruption of the feedback circuits involving the parabrachial nucleus in the pons. It is also discussed whether laterality plays a role in the autonomic nervous system and whether compensatory mechanisms might take over in the subacute phase. This topic is of clinical interest as initial presentation with severe brad...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Hamel, J., Tollefson, T. Tags: Cerebrovascular Disease and Interventional Neurology: Atrial Fibrillation and Miscellaneous Source Type: research
NeurologicManifestations of Neglected Tropical Diseases (P4.295)
CONCLUSIONS: Neurological manifestations of NTDs cause significant morbidity and mortality, although data are limited. The evidence for treatments of neurologic complications is limited for most NTDs. Increased awareness of neurologic manifestations of NTDs can promote early identification and treatment, thereby contributing to ongoing elimination and eradication campaigns.Study Supported by: NADisclosure: Dr. Raibagkar has nothing to disclose. Dr. Berkowitz has received royalty payments from Medmaster and Oxford University Press. Dr. Pritt has nothing to disclose. Dr. Headley-Whyte has nothing to disclose. Dr. Mateen has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Raibagkar, P., Berkowitz, A., Pritt, B., Headley-Whyte, E. T., Mateen, F. Tags: Global Health and Infection Source Type: research
Voltage Gated Calcium Channels Antibody-Associated Autoimmune Encephalitis (P5.228)
ConclusionThis case demonstrates a correlation between a high titer of VGCC antibodies and autoimmune encephalitis. Our patient's initial improvement with steroids and plasma exchange in the face of a negative CT and PET suggests a primary autoimmune process rather than a paraneoplastic etiology, though we admit that it is premature to rule out remission and we will continue to follow herDisclosure: Dr. Alwaki has nothing to disclose. Dr. Lugo has nothing to disclose. Dr. Goshgarian has nothing to disclose. Dr. Ahmad has nothing to disclose. Dr. Hefzy has nothing to disclose. Dr. Mitsias has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Alwaki, A., Lugo, A., Goshgarian, C., Ahmad, O., Hefzy, H., Mitsias, P. Tags: Aging, Dementia, and Cognitive and Behavioral Neurology: Creutzfeldt-Jakob Disease and Subacute Encephalopathies Source Type: research
Paroxysmal Dysarthria and Ataxia after Treatment of Brainstem Encephalitis (P6.053)
CONCLUSIONS: Paroxysmal dysarthria and ataxia is most often recognized as a complication of multiple sclerosis, but it can occur in other neurologic diseases with midbrain lesions near or involving the red nucleus. Effective treatments include carbamazepine, acetazolamide, lamotrigine, and phenytoin.Study Supported by: N/A.Disclosure: Dr. Klaas has nothing to disclose. Dr. Boes has nothing to disclose. Dr. Aksamit has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Klaas, J., Boes, C., Aksamit, A. Tags: Movement Disorders: Miscellaneous Ataxias Source Type: research
The Role of Toll-Like Receptor 3 in Epileptogenesis (I1-2.001)
Conclusion:These preliminary results -in a still ongoing study- indicate a central involvement of seizure induction (epileptogenesis) by TLR3 and provide evidence for future research and possibly drug development to finally change the treatment paradigm of epilepsy from symptomatic seizure control to curable prevention of seizure development.Disclosure: Dr. Benninger has nothing to disclose. Dr. Gross has nothing to disclose. Dr. Steiner has received personal compensation for activities with Actelion and Hoffman La Roche. Dr. Offen has nothing to disclose. Dr. Okun has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Benninger, F., Gross, A., Steiner, I., Offen, D., Okun, E. Tags: Temporal Lobe Epilepsy and Febrile Seizures Data Blitz Presentations Source Type: research
The Role of Toll-Like Receptor 3 in Epileptogenesis (S29.002)
Conclusion:These preliminary results -in a still ongoing study- indicate a central involvement of seizure induction (epileptogenesis) by TLR3 and provide evidence for future research and possibly drug development to finally change the treatment paradigm of epilepsy from symptomatic seizure control to curable prevention of seizure development.Disclosure: Dr. Benninger has nothing to disclose. Dr. Gross has nothing to disclose. Dr. Steiner has received personal compensation for activities with Actelion and Hoffman La Roche. Dr. Offen has nothing to disclose. Dr. Okun has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Benninger, F., Gross, A., Steiner, I., Offen, D., Okun, E. Tags: Epilepsy and Clinical Neurophysiology: Inflammation, Status Epilepticus, and Genetics Source Type: research
